Clinlab Navigator

Vascular Endothelial Growth Factor D

Pulmonary cysts are characteristic of different diseases that include, but are not limited to, Langerhans cell histiocytosis, lymphangioleiomyomatosis (LAM), and Birt-Hogg-Dubé syndrome. Recently, vascular endothelial growth factor type D (VEGF-D) has been found to be elevated in the plasma of some patients with cystic lung disease. Measurement of serum VEGF-D is a noninvasive test to confirm the diagnosis.

VEGF is an angiogenic growth factor that is usually produced by malignant cells. VEGF-D is a ligand for lymphatic growth factor VEGF receptors 2 and 3 (VEGFR-2 and VEGFR-3). Activation of VEGFR-3 can promote lymphatic formation and spread of malignant tumor cells through the lymphatic system to the lymph nodes.Serum VEGF-D is elevated in patients with LAM compared with healthy controls and patients with other forms of cystic lung disease and emphysema. VEGF-D levels inversely correlate with pulmonary function testing. A serum VEGF-D cutoff of greater than 800 pg/mL has a sensitivity of 73% and a specificity of 100% for LAM in patients with CT confirmed cystic lung disease. However, a VEGF-D level less than or equal to 800 pg/mL does not rule out a diagnosis of LAM.

Recent guidelines by the American Thoracic Society/Japanese Respiratory Society recommend that serum VEGF-D be measured in patients with cystic lung disease suggestive of LAM who have no other clinical or radiological confirmatory features besides lung cysts before proceeding with lung biopsy. They recommend that a threshold of greater than 800 pg/mL to be used to diagnose LAM.

Treatment of these patients with sirolimus causes a sustained reduction in VEGF-D levels.

References

Ataya A, Riley L and Brantly ML, Serum vascular endothelial growth factor D in cystic lung disease. JAMA 2019;321:401-402.

McCormackFX, GuptaN, FinlayGR, et al. Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med. 2016;194 (6):748-761.

Updated Articles

Lipoprotein a…

Lipoprotein (a) is a modified form of LDL to which apolipoprotein (a), is covalently bound to apolipoprotein B100 (apoB). The molecular mass can vary between 275 and 800 kDa due to inheritance of more than 40 different allelic LPA variants that…

New Articles

CMV T Cell Immunity

Cytomegalovirus (CMV), a double-stranded DNA virus, belongs to the Herpesviridae family. The prevalence of CMV infection in adults ranges between 30 and 70%. Following CMV infection the virus spreads hematogenously to almost every organ. CMV then…

Blog

SARS-CoV-2…

Some experts estimate that exposure to as few as 1000 SARS-CoV-2 viral particles can cause an infection. This dose of virus could occur by inhaling 1000 infectious viral particles in a single breath, 100 viral particles in 10 breaths, or 10 viral…